William Robinson, M.D. Ph.D.
Bill is a serial entrepreneur, a thought leader in translational immunology, and a practicing rheumatologist.
Bill is also a co-founder of Atreca and Bayhill Therapeutics. He runs a research laboratory that performs translational research investigating the roles of B cells, antibodies, and innate immunity in autoimmunity and arthritis. He is Chief of the Division of Immunology and Rheumatology in the Department of Medicine at Stanford University.
Bill is an inventor on more than twenty patent applications. He received his BS, MD, and PhD degrees from Stanford University and completed his clinical training in internal medicine at the University of California, San Francisco.
Tobias Lanz, M.D.
Tobias is a physician scientist with a strong focus on neurology and translational immunology.
Tobias has more than 10 years of experience in clinical and basic scientific research in the field neuroimmunology and autoimmunity.
Tobias is an inventor on several patent applications. His research accomplishments include the identification of new pathogenic antigens in multiple sclerosis and the development of antibodies to engage novel therapeutic mechanisms in autoimmunity and cancer.
Guy Cavet, Ph.D.
Guy is a biotech executive and computational biologist motivated to improving human health through advances in technology.
Guy was also a founder of Atreca and has twenty years of experience in therapeutics and diagnostic R&D.
Guy is an inventor on over a dozen patent applications. He has built teams in bioinformatics at companies including Rosetta Inpharmatics, Merck and Genentech. He led the data science team behind the Vectra DA clinical diagnostic. His experience also includes establishing and managing partnerships to enable clinical research and drug development.